These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 8555653

  • 41. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S, Singh SV, Samy TS, Krishan A.
    Biochem Pharmacol; 1990 Feb 15; 39(4):723-8. PubMed ID: 2306280
    [Abstract] [Full Text] [Related]

  • 42. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R, Schiestl RH.
    Carcinogenesis; 2006 Feb 15; 27(2):240-4. PubMed ID: 16162646
    [Abstract] [Full Text] [Related]

  • 43. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Feb 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 44. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 45. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 15; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 46. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
    He QY, Jiang B, Zhang HQ, Xue SB.
    Zhongguo Yao Li Xue Bao; 1992 Sep 15; 13(5):416-9. PubMed ID: 1300043
    [Abstract] [Full Text] [Related]

  • 47. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF, Wiley MJ, Wells PG.
    Toxicol Appl Pharmacol; 1994 Feb 15; 124(2):230-41. PubMed ID: 8122268
    [Abstract] [Full Text] [Related]

  • 48. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 15; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 49. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 15; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 50. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB, Zhang Y, Frenkel GD.
    Anticancer Res; 1998 Jan 15; 18(4C):3021-5. PubMed ID: 9713503
    [Abstract] [Full Text] [Related]

  • 51. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW, Franklin MR, Galinsky RE.
    Drug Metab Dispos; 1991 Jan 15; 19(2):498-502. PubMed ID: 1676661
    [Abstract] [Full Text] [Related]

  • 52. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M, Koike K, Rho MC, Kuwano M, Kishiye T, Komiyama K.
    Anticancer Drug Des; 2001 Jan 15; 16(4-5):255-60. PubMed ID: 12049484
    [Abstract] [Full Text] [Related]

  • 53. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May 15; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 54. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 55. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J, Astor MB, Taub RN, Baker MA, Bhalla K, Gervasoni JE, Rosado M, Stewart V, Krishna S, Hindenburg AA.
    Cancer Res; 1989 Aug 01; 49(15):4120-5. PubMed ID: 2568167
    [Abstract] [Full Text] [Related]

  • 56. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X, Sui M, Fan W.
    Anticancer Res; 2005 Aug 01; 25(3B):1953-62. PubMed ID: 16158930
    [Abstract] [Full Text] [Related]

  • 57. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar 01; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 58. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
    Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, Fritz G, Osmak M, Ambriovic-Ristov A.
    Mol Pharmacol; 2008 Jul 01; 74(1):298-306. PubMed ID: 18441044
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr 01; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 60. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
    Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler R.
    Cancer Res; 1993 Apr 01; 53(7):1583-9. PubMed ID: 8453627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.